Sanofi-Regeneron Mechanisms of Type 2 Inflammation Mid-career Award

About this program

The Dermatology Foundation, supported by a generous contribution from Sanofi–Regeneron, offers the Mechanisms of Type 2 Inflammation Mid‑Career Award to fund mid‑career investigators with an established record in basic, clinical, or translational research aimed at generating new mechanistic insights into Type 2 inflammatory skin disorders. Funded projects should advance understanding of dermatologic mechanisms related to Type 2 inflammation. Eligible applicants must conduct research in the U.S. under the sponsorship of an ACGME‑approved dermatology department/division and satisfy the Foundation’s general and award‑specific requirements at the time of funding; applicants from minority and underserved populations are encouraged to apply. Applications open October 2026 via the DF Innovator Mid‑career Research Award Portal with a December 1, 2026 deadline and renewals due January 1, 2027.